05Aug
Defying gravity: US M&A H1 2019: Pharma chases innovation through deals
The need to replenish intellectual property has pushed the pharma industry to the highest-performing sector by M&A value. In the pharmaceuticals, medical and biotech sector, deal value in the first half of the year was up 142 percent to US$172...
By:
White & Case LLP
Related
NATIVE AMERICAN LAW - Key Ruling on Native American Sovereign Immunity Stands—for Now - The Fou...
Read More >
Die Europäische Kommission legt beihilferechtliche Eckpunkte vor - Staatliche Unterstützungsmaßnahm...
Read More >
On January 10, 2020, the Federal Trade Commission and the United States Department of Justice Antitr...
Read More >
The New York State Senate and Assembly have passed two bills amending the New York Labor Law (NYLL) ...
Read More >
The coronavirus pandemic is creating both opportunities and risks for Florida’s contractors. For ex...
Read More >
Another Future of Work Hearing Scheduled. The House Higher Education and Workforce Development Subco...
Read More >